Titre : Séquence instable d'ADN

Séquence instable d'ADN : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reproducibility of Results
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Séquence instable d'ADN : Questions médicales les plus fréquentes", "headline": "Séquence instable d'ADN : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Séquence instable d'ADN : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Séquence instable d'ADN" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composants de génome", "url": "https://questionsmedicales.fr/mesh/D040481", "about": { "@type": "MedicalCondition", "name": "Composants de génome", "code": { "@type": "MedicalCode", "code": "D040481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.024" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sites fragiles de chromosome", "alternateName": "Chromosome Fragile Sites", "url": "https://questionsmedicales.fr/mesh/D043283", "about": { "@type": "MedicalCondition", "name": "Sites fragiles de chromosome", "code": { "@type": "MedicalCode", "code": "D043283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.024.189.610" } } } ], "about": { "@type": "MedicalCondition", "name": "Séquence instable d'ADN", "alternateName": "DNA Sequence, Unstable", "code": { "@type": "MedicalCode", "code": "D043243", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Omary Mzava", "url": "https://questionsmedicales.fr/author/Omary%20Mzava", "affiliation": { "@type": "Organization", "name": "Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA." } }, { "@type": "Person", "name": "Adrienne Chang", "url": "https://questionsmedicales.fr/author/Adrienne%20Chang", "affiliation": { "@type": "Organization", "name": "Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA." } }, { "@type": "Person", "name": "Amy Steadman", "url": "https://questionsmedicales.fr/author/Amy%20Steadman", "affiliation": { "@type": "Organization", "name": "Global Health Labs, Bellevue, WA, USA." } }, { "@type": "Person", "name": "Iwijn De Vlaminck", "url": "https://questionsmedicales.fr/author/Iwijn%20De%20Vlaminck", "affiliation": { "@type": "Organization", "name": "Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA." } }, { "@type": "Person", "name": "Bertrand Jordan", "url": "https://questionsmedicales.fr/author/Bertrand%20Jordan", "affiliation": { "@type": "Organization", "name": "UMR 7268 ADÉS, Aix-Marseille, Université/EFS/ CNRS ; CoReBio PACA, case 901, Parc scientifique de Luminy, 13288 Marseille Cedex 09, France." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Portuguese Version of the HLS-EU-Q6 and HLS-EU-Q16 Questionnaire: Psychometric Properties.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36833587", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20042892" } }, { "@type": "ScholarlyArticle", "name": "Association between hemoglobin glycation index and non-alcoholic fatty liver disease.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36824362", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1094101" } }, { "@type": "ScholarlyArticle", "name": "[Validation of a Dispositional Hope Scale for Chilean children and adolescents].", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/37358111", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.32641/andespediatr.v94i2.4055" } }, { "@type": "ScholarlyArticle", "name": "Machine learning classifiers predict key genomic and evolutionary traits across the kingdoms of life.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36747072", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-28965-7" } }, { "@type": "ScholarlyArticle", "name": "Automatic electronic reporting improved the completeness of AMI and stroke incident surveillance in Tianjin, China: a modeling study.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36747283", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12963-023-00300-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Génome", "item": "https://questionsmedicales.fr/mesh/D016678" }, { "@type": "ListItem", "position": 5, "name": "Composants de génome", "item": "https://questionsmedicales.fr/mesh/D040481" }, { "@type": "ListItem", "position": 6, "name": "Séquence instable d'ADN", "item": "https://questionsmedicales.fr/mesh/D043243" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Séquence instable d'ADN - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Séquence instable d'ADN", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Séquence instable d'ADN", "description": "Comment diagnostiquer une séquence instable d'ADN ?\nQuels tests sont utilisés pour détecter des séquences instables ?\nLes tests génétiques sont-ils fiables ?\nQuels signes cliniques indiquent une instabilité d'ADN ?\nPeut-on détecter l'instabilité d'ADN par imagerie ?", "url": "https://questionsmedicales.fr/mesh/D043243?mesh_terms=Reproducibility+of+Results&page=998#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Séquence instable d'ADN", "description": "Quels sont les symptômes d'une séquence instable d'ADN ?\nL'instabilité d'ADN cause-t-elle des douleurs ?\nY a-t-il des symptômes précoces à surveiller ?\nLes symptômes sont-ils héréditaires ?\nL'instabilité d'ADN affecte-t-elle le développement ?", "url": "https://questionsmedicales.fr/mesh/D043243?mesh_terms=Reproducibility+of+Results&page=998#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Séquence instable d'ADN", "description": "Peut-on prévenir l'instabilité d'ADN ?\nLe mode de vie influence-t-il l'instabilité d'ADN ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nY a-t-il des recommandations diététiques ?\nLes vaccinations jouent-elles un rôle ?", "url": "https://questionsmedicales.fr/mesh/D043243?mesh_terms=Reproducibility+of+Results&page=998#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Séquence instable d'ADN", "description": "Quels traitements existent pour l'instabilité d'ADN ?\nLa chirurgie est-elle une option de traitement ?\nLes traitements sont-ils personnalisés ?\nY a-t-il des essais cliniques disponibles ?\nLes traitements sont-ils efficaces ?", "url": "https://questionsmedicales.fr/mesh/D043243?mesh_terms=Reproducibility+of+Results&page=998#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Séquence instable d'ADN", "description": "Quelles complications peuvent survenir ?\nL'instabilité d'ADN peut-elle entraîner des décès ?\nY a-t-il des complications à long terme ?\nLes complications sont-elles réversibles ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D043243?mesh_terms=Reproducibility+of+Results&page=998#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Séquence instable d'ADN", "description": "Quels sont les facteurs de risque d'instabilité d'ADN ?\nL'âge est-il un facteur de risque ?\nLe sexe influence-t-il le risque ?\nLes habitudes alimentaires affectent-elles le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D043243?mesh_terms=Reproducibility+of+Results&page=998#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une séquence instable d'ADN ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par séquençage génétique et analyse des mutations." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter des séquences instables ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme le PCR et le séquençage Sanger sont couramment utilisés." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils fiables ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques sont généralement fiables pour détecter des anomalies." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une instabilité d'ADN ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des cancers héréditaires ou des troubles neurologiques peuvent indiquer cela." } }, { "@type": "Question", "name": "Peut-on détecter l'instabilité d'ADN par imagerie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'instabilité d'ADN nécessite des tests moléculaires, pas d'imagerie." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une séquence instable d'ADN ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, incluant des cancers, des troubles immunitaires et neurologiques." } }, { "@type": "Question", "name": "L'instabilité d'ADN cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, par des maladies associées, mais l'instabilité elle-même ne cause pas de douleur." } }, { "@type": "Question", "name": "Y a-t-il des symptômes précoces à surveiller ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies de croissance ou des infections fréquentes peuvent être des signes." } }, { "@type": "Question", "name": "Les symptômes sont-ils héréditaires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Certains symptômes peuvent être héréditaires, surtout dans les syndromes liés à l'instabilité." } }, { "@type": "Question", "name": "L'instabilité d'ADN affecte-t-elle le développement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des retards de développement ou des malformations congénitales." } }, { "@type": "Question", "name": "Peut-on prévenir l'instabilité d'ADN ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention, mais un dépistage précoce peut aider." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il l'instabilité d'ADN ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme le tabagisme et l'exposition aux toxines peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider à la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques permettent d'identifier les individus à risque et de surveiller." } }, { "@type": "Question", "name": "Y a-t-il des recommandations diététiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants peut aider à réduire le stress oxydatif sur l'ADN." } }, { "@type": "Question", "name": "Les vaccinations jouent-elles un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui augmentent le risque de cancer." } }, { "@type": "Question", "name": "Quels traitements existent pour l'instabilité d'ADN ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie génique, la chimiothérapie et la surveillance régulière." } }, { "@type": "Question", "name": "La chirurgie est-elle une option de traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chirurgie peut être nécessaire pour retirer des tumeurs associées à l'instabilité." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction des mutations spécifiques détectées." } }, { "@type": "Question", "name": "Y a-t-il des essais cliniques disponibles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, plusieurs essais cliniques étudient de nouveaux traitements pour ces conditions." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité varie selon le type de mutation et la maladie associée, mais des progrès sont faits." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des cancers, des maladies auto-immunes et des troubles neurologiques." } }, { "@type": "Question", "name": "L'instabilité d'ADN peut-elle entraîner des décès ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies associées peuvent être mortelles si non traitées." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications chroniques comme des cancers ou des troubles de la reproduction peuvent survenir." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi médical régulier et des traitements adaptés aux symptômes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'instabilité d'ADN ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, l'exposition à des agents cancérigènes et des infections." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'instabilité d'ADN augmente avec l'âge en raison de l'accumulation de mutations." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines conditions liées à l'instabilité d'ADN peuvent être plus fréquentes chez un sexe." } }, { "@type": "Question", "name": "Les habitudes alimentaires affectent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en nutriments peut augmenter le risque de mutations." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des produits chimiques et à des radiations peut augmenter le risque." } } ] } ] }

Sources (10000 au total)

Association between hemoglobin glycation index and non-alcoholic fatty liver disease.

The hemoglobin glycation index (HGI) reflects biological variability in hemoglobin A1c. Even so, studies on the relationship between HGI and non-alcoholic fatty liver disease (NAFLD) are limited. Ther... This was a retrospective study based on physical examination data from Japan. Patients were divided into quartiles (Q1-Q4) according to their HGI level; the lowest quartile (Q1) was used as the refere... A total of 14280 patients were eligible for inclusion in this study; 2515 had NAFLD. Patients in the NAFLD group had higher levels of HGI than patients in the non-NAFLD group. Increases in HGI correla... HGI was an independent risk factor for NAFLD, and BMI partly mediated the association between HGI and NAFLD....

[Validation of a Dispositional Hope Scale for Chilean children and adolescents].

According to Snyder's theory, hope is defined as a dispositional attribute consisting of two dimensions, agency and pathway thinking. This construct has been widely studied because of its association ... To assess the psychometric properties of the Dispositional Hope Scale for Chilean children and adolescents (NNA, for its acronym in Spanish).... The study was conducted on 331 NNA, aged 10 to 20 years, from different educational centers in the country. Reliability was tested with Cronbach's alpha coefficient. In addition, one-factor vs two-fac... The scale showed a Cronbach's alpha coefficient of 0.89 and an adequate fit to the two-factor model, keeping the original structure proposed by Snyder et al. It is negatively related to depressive sym... The NNA Hope Scale shows appropriate psychometric properties for its use on Chilean NNA population....

Automatic electronic reporting improved the completeness of AMI and stroke incident surveillance in Tianjin, China: a modeling study.

AMI and stroke are the leading causes of premature mortality and hospitalizations in China. Incidence data at the population level for the two diseases is limited and the reliability and completeness ... We applied the DisMod II program to model the incidence of AMI and stroke from other epidemiological indicators. Inputs include mortality rates from Tianjin's mortality surveillance system, and the po... The age and sex standardized modeled incidence per 100,000 person-year decreased (p < 0.0001) from 138 in 2007 to 119 in 2015 for AMI and increased (p < 0.0001) from 520 in 2007 to 534 in 2015 for str... Completeness of AMI and stroke incidence surveillance was low in Tianjin but has improved in recent years primarily owing to the incorporation of an automatic reporting component into the information ...

The usefulness of preoperative CT in colon cancer staging: impact of radiologists' experience.

To assess the agreement between radiologists in the detection of specific features related to T- and N-stage and evaluate accuracy in colon cancer staging.... Patients who underwent contrast-enhanced computed tomography (CECT) before surgery were enrolled and evaluated by three radiologists with different experience. Pathological data were used as the refer... Seventy five patients were evaluated. The reliability analysis was moderate to substantial for tumor location (κ = 0.853), T staging (κ = 0.531), tumor bulging (κ = 0.478), fat stranding (κ = 0.490), ... Reader's experience is one of the most important factors associated with the correct classification of colon cancer. Moreover, CECT can help depict radiological features independently associated with ...

[Psychometric Evaluation of a Single-Item-Screener for Sleep Disturbances].

Sleep disturbances are one of the most prevalent health complaints in the general population. Thus, the need for validated screening instruments and prevention measures is high. The aim of the current... Data from Saxony Longitudinal Study (SLS) is being analyzed. Based on data of 32nd wave (n=321, 172 women, 149 men, M age=48.42, SD=0.64), the G-Score Item #3 ("Have you had the following complaints i... Retestreliability for the G-Score Item #3 is 0.70 (p<0.001). Correlation with the Jenkins Sleep Scale (JSS) was r=0.79 (p<0.01). The area under the curve (AUC) is 0.92, providing evidence for a very g... This study provides evidence for the use of the G-Score Item #3 as a screening instrument for sleep disturbances by showing good psychometric properties and brevity....

Translation and cross-cultural adaptation of the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire.

There is a paucity of international data regarding self-reported lower extremity lymphedema and quality of life after surgery for gynecological cancer. Validated questionnaires are emerging, but trans... To translate and culturally adapt the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire for a Norwegian population.... Permission to use the original English versions of the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire for translation was obtained. The question... Twelve patients completed the questionnaires twice. Cronbach's alpha was 0.75 for the Gynecologic Cancer Lymphedema Questionnaire and 0.89 for the Lower Extremity Lymphedema Screening Questionnaire. T... Translation and cross-cultural adaptation of these internationally validated patient-reported outcomes questionnaires for survivors of lower extremity lymphedema in gynecological cancer was feasible. ...

Nurses' Work Methods Assessment Scale: a study of content validation.

To develop and validate the content of the Nurses' Work Methods Assessment Scale.... Methodological study conducted between January and February 2022, based on the Quality Standards for Nursing Care and Imogene King's framework. A literature review was previously undertaken to design ... The initial version consisted of 40 items organized in four work methods identified in the literature. In the first dimension, from ten items, seven were considered, and one was reformulated. Seven of... The involvement of experts has become pivotal in the development and validation of the items, providing confidence to the continuity of psychometric procedures....